Zurn Elkay Water Solutions (ZWS) director receives 2,900-share grant

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Zurn Elkay Water Solutions director Thomas Christopoul reported receiving 2,900 shares of common stock on February 10, 2026 through a restricted stock unit grant. The award vested immediately but will not be paid out until six months after he stops serving as a director.

After this transaction, Christopoul beneficially owns 117,171 shares of Zurn Elkay common stock, held directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider CHRISTOPOUL THOMAS

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,900	$0.00	--

Holdings After Transaction: Common Stock — 117,171 shares (Direct)

Footnotes (1)

[object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/10/2026 - 08:42 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CHRISTOPOUL THOMAS

(Last)

(First)

(Middle)

511 W. FRESHWATER WAY

(Street)

MILWAUKEE

53204

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Zurn Elkay Water Solutions Corp [ ZWS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/10/2026		A		2,900	A	⁽¹⁾	117,171	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted stock unit grant, which vested immediately, but is not paid out until six months after the Reporting Person's cessation of service as a director.

Remarks:

	/s/ Jeffrey J. LaValle under Power of Attorney for Thomas D. Christopoul	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What does the latest Zurn Elkay (ZWS) Form 4 filing show?

The Form 4 shows director Thomas Christopoul received 2,900 Zurn Elkay common shares on February 10, 2026 via a restricted stock unit grant. The units vested immediately but will be paid six months after he ends his board service.

How many Zurn Elkay (ZWS) shares did the director receive in this grant?

Director Thomas Christopoul received 2,900 shares of Zurn Elkay common stock through a restricted stock unit grant. The grant vested immediately on February 10, 2026 but payment is deferred until six months after his cessation of service as a director.

When will the granted Zurn Elkay (ZWS) restricted stock units be paid out?

The restricted stock unit grant to director Thomas Christopoul is paid out six months after he ceases serving as a director. Although the 2,900-share award vested immediately on February 10, 2026, settlement of the shares is deferred under this structure.

How many Zurn Elkay (ZWS) shares does Thomas Christopoul now beneficially own?

Following the reported award, director Thomas Christopoul beneficially owns 117,171 shares of Zurn Elkay common stock. The filing indicates these shares are held directly, reflecting his total beneficial ownership after the 2,900-share restricted stock unit grant.

Was there a purchase price for the Zurn Elkay (ZWS) shares granted to the director?

The transaction reports a price per share of $0.0000 for the 2,900 Zurn Elkay common shares. This indicates the award was a compensatory restricted stock unit grant to director Thomas Christopoul rather than an open-market purchase of company stock.

What type of transaction code appears in the Zurn Elkay (ZWS) Form 4?

The transaction is coded as “A” for an acquisition of non-derivative securities. It reflects a grant of 2,900 shares of Zurn Elkay common stock to director Thomas Christopoul under a restricted stock unit arrangement, which vested immediately on February 10, 2026.